CANDIDA SEPSIS IN SURGICAL PATIENTS

被引:65
作者
EUBANKS, PJ [1 ]
DEVIRGILIO, C [1 ]
KLEIN, S [1 ]
BONGARD, F [1 ]
机构
[1] UCLA,HARBOR MED CTR,DEPT SURG,TORRANCE,CA 90509
关键词
D O I
10.1016/S0002-9610(05)80666-X
中图分类号
R61 [外科手术学];
学科分类号
摘要
Candidemia in critically ill patients is a significant source of mortality. To identity perioperative risk factors accounting for patient death, we performed a retrospective study of 46 surgical patients with fungemia during the period from 1981 to 1990. Twenty patients survived (43%), and 26 died (57%). Mortality was associated with age older than 46 (p <0.02, unpaired Student's t-test) and concomitant renal failure, hepatic failure, postoperative shock, or adult respiratory distress syndrome (p <0.0001, p <0.0001, and p <0.05, respectively, chi(2) test). Survival was not influenced by the presence of diabetes, chronic obstructive pulmonary disease, gastrointestinal hemorrhage, pneumonia, alcohol consumption, steroid use, or enteral/parental nutrition. Bacterial septicemia developed in 26 patients (11 lived, 15 died) and typically preceded or was concomitant with the onset of fungal sepsis (88%). Candida albicans was the fungal species most commonly isolated from blood cultures (30 of 46). It was cultured from other sites in addition to blood in 30 patients. Candidemia carries a higher risk of mortality in older patients and in those with multiple organ dysfunction. Other immunocompromised conditions such as diabetes and steroid use did not increase mortality. These findings suggest that the pathogenicity of Candida sepsis is not solely related to opportunistic superinfections but may reflect failure of other host defense mechanisms. Moreover, the frequent occurrence of bacterial septicemia prior to the development of Candida sepsis further emphasizes the importance of fungal surveillance cultures to detect early fungal colonization in the critically ill.
引用
收藏
页码:617 / 620
页数:4
相关论文
共 17 条
[1]  
CALDERONE RA, 1989, MYCOSES, V32, P12
[2]  
EDWARDS JE, 1992, CLIN INFECT DIS S1, V14, P106
[3]  
EDWARDS JE, 1986, DISSEMINATED CANDIDI
[4]   CANDIDA INFECTION OF GASTROINTESTINAL TRACT [J].
ERAS, P ;
SHERLOCK, P ;
GOLDSTEIN, MJ .
MEDICINE, 1972, 51 (05) :367-+
[5]  
GHANNOUM MA, 1988, MYCOSES, V31, P543, DOI 10.1111/j.1439-0507.1988.tb04408.x
[6]   PATHOGENICITY DETERMINANTS OF CANDIDA [J].
GHANNOUM, MA ;
ABUELTEEN, KH .
MYCOSES, 1990, 33 (06) :265-282
[7]   LABORATORY DIAGNOSIS OF INVASIVE CANDIDIASIS [J].
JONES, JM .
CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (01) :32-45
[8]   NEW ANTIMICROBIAL AGENTS UNDER CLINICAL INVESTIGATION - SECONDARY MYCOSIS IN SURGERY - TREATMENT WITH FLUCONAZOLE [J].
KUJATH, P ;
LERCH, K .
INFECTION, 1989, 17 (02) :111-117
[9]   ANTIBIOTICS AND FUNGOUS INFECTIONS [J].
LIPNIK, MJ ;
KLIGMAN, AM ;
STRAUSS, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1952, 18 (03) :247-260
[10]  
MATTHEWS R C, 1988, Mycoses, V31, P34